|Day Low/High||2.84 / 2.90|
|52 Wk Low/High||1.20 / 2.60|
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AOSL, ARES, BREW, CHTR, FSIC, GBDC, IPAR, LUK, LUNA, NRCIA, ODP, OLED, PIP, STRL, VIPS Downgrades: BCRH, CBNK, DF, HALL, MDVN, MYGN, NMR, NYRT, SGU, TCRD, TEO Initiations: APPF, GLPI, SPNE, TDOC Read on to get TheStreet Quant Ratings' detailed report:
- PharmAthene has received a $5 million initial payment from SIGA -
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Stocks with insider trader activity include PIP, TER and AMBA
Reduced Dosing Meets Important U.S. Government Objective
Keep these health care stocks under $10 on your breakout trading radar.
PharmAthene Selected to Serve on Creditors' Committee
Companies Combine Expertise and Resources to Advance Medical Countermeasures Development and Manufacturing
Investors in PharmAthene Inc saw new options become available this week, for the October 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PIP options chain for the new October 18th contracts and identified the following call contract of particular interest.
PharmAthene (PIP) soared Monday after a Delaware court ruled SIGA Technologies (SIGA) must pay a lump sum in damages to PharmAthene.
Court Also Awards Prejudgment Interest and Reasonable Attorneys' and Expert Witness Fees